Literature DB >> 33275681

Does ABO and RhD matching matter for platelet transfusion?

Nancy M Dunbar1.   

Abstract

Platelets express ABO antigens and are collected in plasma, which contains ABO antibodies as would be consistent with the donor ABO group. Platelet ABO antigens that are incompatible with recipient ABO antibodies may have accelerated clearance from circulation and result in lower count increments. ABO antibodies that are passively transferred from donor plasma may result in hemolysis of recipient red blood cells. Although platelets do not express Rh antigens, they contain small numbers of intact red blood cells or fragments, which can lead to alloimmunization in the recipient. Alloimmunization to the RhD antigen may occur when platelets obtained from RhD-positive donors are transfused to RhD-negative recipients. All of these compatibility considerations must be balanced against the available supply, which may be limited due to the 5- to 7-day shelf life of platelets. This articles describes considerations for platelet ABO and RhD selection for platelet transfusions, including the impact of major ABO incompatibility on count increments, the risks of hemolysis associated with minor ABO incompatibility, and the risk of RhD alloimmunization when RhD-negative patients receive platelets obtained from RhD-positive donors.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33275681      PMCID: PMC7727583          DOI: 10.1182/hematology.2020000135

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  38 in total

1.  Blood group A and B antigens are strongly expressed on platelets of some individuals.

Authors:  B R Curtis; J T Edwards; M J Hessner; J P Klein; R H Aster
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

2.  How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products.

Authors:  Magali J Fontaine; Anne M Mills; Susan Weiss; Wan-Jen Hong; Maurene Viele; Lawrence T Goodnough
Journal:  Transfusion       Date:  2012-03-13       Impact factor: 3.157

3.  Platelet transfusion - the art and science of compromise.

Authors:  Joan Cid; Sarah K Harm; Mark H Yazer
Journal:  Transfus Med Hemother       Date:  2013-04-26       Impact factor: 3.747

Review 4.  Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma.

Authors:  Olle Berséus; Kjell Boman; Shawn C Nessen; Lars A Westerberg
Journal:  Transfusion       Date:  2013-01       Impact factor: 3.157

Review 5.  ABO incompatible platelets: risks versus benefit.

Authors:  Nancy M Dunbar; Deborah L Ornstein; Larry J Dumont
Journal:  Curr Opin Hematol       Date:  2012-11       Impact factor: 3.284

6.  Prospective surveillance of D- recipients of D+ apheresis platelets: alloimmunization against D is not detected.

Authors:  Robert Weinstein; Amie Simard; Jillian Ferschke; Michelle Vauthrin; Jeffrey A Bailey; Mindy Greene
Journal:  Transfusion       Date:  2014-12-19       Impact factor: 3.157

7.  The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia.

Authors:  Darrell J Triulzi; Susan F Assmann; Ronald G Strauss; P M Ness; John R Hess; Richard M Kaufman; Suzanne Granger; Sherrill J Slichter
Journal:  Blood       Date:  2012-04-10       Impact factor: 22.113

Review 8.  Platelet storage media.

Authors:  H Gulliksson
Journal:  Vox Sang       Date:  2014-06-27       Impact factor: 2.144

9.  Dilution is not the solution: acute hemolytic transfusion reaction after ABO-incompatible pooled platelet transfusion.

Authors:  Juliana Guarente; Mary Harach; Joy Gould; Julie K Karp; Alexis R Peedin
Journal:  Immunohematology       Date:  2019-09

Review 10.  ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.

Authors:  Cassandra D Josephson; Marta-Inés Castillejo; Kathleen Grima; Christopher D Hillyer
Journal:  Transfus Apher Sci       Date:  2010-01-19       Impact factor: 1.764

View more
  1 in total

Review 1.  Platelet transfusion refractoriness: how do I diagnose and manage?

Authors:  Claudia S Cohn
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.